Quarterly Sales

Second quarter

Pharma

Of biopharma's top 25 companies, 9 had double-digit sales bumps

Biopharma sales boomed in Q2. Of the top 25 revenue companies, nine had YoY double-digit increases and 13 saw sequential increases of at least 10%.

Kevin Dunleavy Aug 12, 2026 11:47am

BBIO

BridgeBio’s Attruby cruises toward blockbuster land

Aug 11, 2026 11:22am

Eli Lilly Lilly

Amid struggles of Lilly's Foundayo, injectables still on a roll

Aug 5, 2026 11:42am

Gilead

Gilead's Yeztugo faces growth outlook questions

Aug 5, 2026 10:44am

Pfizer

More reductions for Pfizer as it tacks on $2.5B in cost savings

Aug 4, 2026 11:33am

Skyrizi

With $5.5B sales, AbbVie's Skyrizi matches Humira's best quarter

Jul 31, 2026 11:18am